Document from CIS Legislation database © 2003-2024 SojuzPravoInform LLC

RESOLUTION OF THE MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS

of February 10, 2023 No. 29

About establishment of the Republican form of medicines for 2023

Based on part one of article 38-1 of the Law of the Republic of Belarus of June 18, 1993 No. 2435-XII "About health care", the paragraph of the fifteenth subitem 8.8-5 of Item 8 and subitem 9.1 of Item 9 of the Regulations on the Ministry of Health of the Republic of Belarus approved by the resolution of Council of Ministers of the Republic of Belarus of October 28, 2011 No. 1446, the Ministry of Health of the Republic of Belarus DECIDES:

1. Establish the Republican form of medicines for 2023 according to appendix.

2. This resolution becomes effective after its official publication.

Minister

D.L.Pinevich

 

Appendix

to the Resolution of the Ministry of Health of the Republic of Belarus of February 10, 2023 No. 29

The republican form of medicines for 2023


payment order

Pharmacological subgroup anatomo - therapeutic and chemical classification system of medicines

International non-proprietary name of medicine

Dosage forms, dosages

Reference information about the medicine price, conventional units

The dosage forms, dosages made and (or) which are packed up in the Republic of Belarus

Note

1

2

3

4

5

6

7

1

A Digestive tract and metabolism

1.1

Means A02 for treatment of the conditions connected with acidity violation:

1.1.1

A02A Antatsidny means

The connections containing hydroxide of aluminum and magnesium

Suspension for internal application

Suspension for internal application

Tablets (chewable tablets)

Tablets (chewable tablets)

Aluminum phosphate

Suspension

Suspension

1.1.2

A02B the Antiulcer means and means applied in case of gastroezofagealny reflux disease

Lansoprazol

Capsules (capsules kishechnorastvorimy) 15 mg

Capsules (capsules kishechnorastvorimy) 30 mg

Capsules of 30 mg

Omeprazol

The powder lyophilized for preparation of solution for intravenous administration (lyophilisate for preparation of solution for intravenous administration) 40 mg

0,983

The powder lyophilized for preparation of solution for intravenous administration (lyophilisate for preparation of solution for intravenous administration) 40 mg

Capsules of 10 mg

Capsules (capsules kishechnorastvorimy) 20 mg

Capsules (capsules kishechnorastvorimy) 20 mg

Pantoprazol

The lyophilized powder (powder) for preparation of solution for intravenous administration of 40 mg

0,976

The lyophilized powder for preparation of solution for intravenous administration of 40 mg

The tablets covered with kishechnorastvorimy cover (tablets kishechnorastvorimy), 40 mg

The tablets covered with kishechnorastvorimy cover, 40 mg

Ranitidine

Solution for injections (solution for intravenous and intramuscular administration) 25 mg/ml 2 ml

Solution for intravenous and intramuscular administration of 25 mg/ml 2 ml

The tablets covered with cover, 75 mg

The tablets covered with cover, 150 mg

The tablets covered with cover, 150 mg

The tablets covered with cover, 300 mg

Famotidin

The lyophilized powder for injections (for preparation of solution for intravenous administration) 20 mg

1,467

The tablets covered with cover, 20 mg

The tablets covered with cover, 20 mg

The tablets covered with cover, 40 mg

The tablets covered with cover, 40 mg

1.2

Means A03 for treatment of functional violations of digestive tract:

1.2.1

The Means A03A applied in case of dysfunction of intestines

Synthetic spazmolitichesky means, amides with tertiary amino group (platifillin)

Solution for hypodermic introduction of 2 mg/ml 1 ml

Papaverine

Solution for injections of 20 mg/ml 2 ml

Solution for injections of 20 mg/ml 2 ml

Suppositories rectal 20 mg

Drotaverin

Solution for intravenous and intramuscular administration (for injections) 20 mg/ml 2 ml

Solution for intravenous and intramuscular administration (for injections) 20 mg/ml 2 ml

Tablets of 40 mg

Tablets of 40 mg

Tablets of 80 mg

Silicones (in children's practice)

Drops for intake of 40 mg/ml 30 ml, 50 ml

Drops for intake of 40 mg/ml 30 ml, 50 ml

Drops for intake of 66,66 of mg/ml of 30 ml

Drops for internal application of 300 mg/ml 30 ml

1.2.2

Means A03B on the basis of belladonna and its derivatives

Atropine

Solution for injections of 1 mg/ml 1 ml

Solution for injections of 1 mg/ml 1 ml

1.2.3

Spazmolitiki's A03D in combination with analgetics

Pitofenon in combination with analgetics

Solution for intramuscular introduction (for injections)

Solution for intramuscular introduction

1.2.4

Pro-kinetics A03F

Domperidon

Tablets of 10 mg

Tablets of 10 mg

The tablets covered with cover, 10 mg

The tablets covered with cover, 10 mg

Metoklopramid

Solution for intravenous and intramuscular administration (for injections) 5 mg/ml 2 ml

Solution for intravenous and intramuscular administration of 5 mg/ml 2 ml

Tablets of 10 mg

Tablets of 10 mg

1.3

A04 Protivorvotny means and means for elimination of nausea:

A04A Protivorvotny means and means for elimination of nausea

Aprepitant

Capsules of 125 mg, capsules of 80 mg

18,1

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Granisetron (in children's practice)

Concentrate for preparation of solution for infusions of 1 mg/ml 3 ml

Solution for injections of 1 mg/ml 3 ml

18,262

The tablets covered with cover, 1 mg

Ondansetron

Solution for intravenous and intramuscular administration (for injections) 2 mg/ml 2 ml

Solution for intravenous and intramuscular administration of 2 mg/ml 2 ml

Solution for intravenous and intramuscular administration (for injections) 2 mg/ml 4 ml

Solution for intravenous and intramuscular administration of 2 mg/ml 4 ml

The tablets covered with cover, 4 mg

The tablets covered with cover, 8 mg

0,217

The tablets covered with cover, 8 mg

Tropisetron

Solution for intravenous administration (for injections) 1 mg/ml 5 ml

Solution for intravenous administration (for injections) 1 mg/ml 5 ml

Capsules of 5 mg

Capsules of 5 mg

1.4

Means A05 for treatment of diseases of liver and biliary tract:

1.4.1

Means A05A for treatment of diseases of biliary tract

Ursodeoksikholevy (ursodezoksikholevy) acid

Capsules of 250 mg

Capsules of 250 mg

Capsules of 300 mg

Capsules of 300 mg

Suspension for intake of 250 mg / 5 ml,
100 ml, 250 ml

Suspension for intake of 250 mg / 5 ml,
100 ml, 250 ml

Other medicines in case of diseases of biliary tract (artichoke extract)

Solution for intake of 120 ml

Solution for intake of 120 ml

Capsules of 100 mg

Capsules of 100 mg

The tablets covered with cover, 200 mg

The tablets covered with cover, 200 mg

1.4.2

Means A05B for treatment of diseases of liver, lipotropny means

Ornitina aspartate

Concentrate for preparation of solution for infusions of 500 mg/ml 10 ml

4,847

Concentrate for preparation of solution for infusions of 500 mg/ml

Solution for infusions (for injections) 100 mg/ml 10 ml

Solution for infusions of 100 mg/ml 10 ml

Powder for preparation of solution for internal application of 3 g

Powder for preparation of solution for internal application of 3 g

Granules for preparation of solution for intake of 5 g

0,734

Silimarin

The tablets covered with cover, 35 mg

The tablets covered with cover, 35 mg

Phospholipids/glycyrrhizic acid

Lyophilisate for preparation of solution for intravenous administration of 2,5 of

Capsules

Capsules

Essentsialny phospholipids

Solution for intravenous administration of 50 mg/ml 5 ml

Solution for intravenous administration of 50 mg/ml 5 ml

Capsules

Capsules

1.5

A06 Depletive:

A06A Depletive

Liquid paraffin (vaseline oil)

Oil of 30 ml

Oil of 30 ml

Bisakodil

Tablets are the kishechnorastvorimy, covered cover (the tablet covered with kishechnorastvorimy cover), 5 mg

Tablets are kishechnorastvorimy, covered with cover, 5 mg

Castor oil

Oil for intake of 30 g

Oil for intake of 30 g

Pikosulfat of sodium

Drops for intake (for internal application) mg/ml 7,5

Drops for internal application of 7,5 of mg/ml

Magnesium sulfate

Powder for preparation of solution for internal application of 10 g, 20 g

Powder for preparation of solution for internal application of 10 g, 20 g

Laktuloza

Syrup of 500-670 mg/ml
150 ml-1 000 ml,
in packets of 15 ml

Syrup of 667-670 mg/ml 150 ml-500 of ml
in packets of 15 ml

Macrogoal

Powder for preparation of solution for intake (for internal application) 10 g

Powder for preparation of solution for intake (for internal application) 10 g

Macrogoal in combinations

Powder for preparation of solution for intake (for internal application)

Powder for preparation of solution for intake (for internal application)

1.6

A07 Antidiarrheal means, anti-inflammatory, anti-infectious means for intestines:

1.6.1

A07A the Antimicrobic means operating on intestines

Nystatin

The tablets covered with cover, 500 000 ED

The tablets covered with cover, 500 000 ED

Suppositories rectal 250 000 ED

Suppositories rectal 500 000 ED

Suppositories rectal 500 000 ED

Nifuroksazid

Suspension for internal application of 44 mg/ml 90 ml

Suspension for internal application of 44 mg/ml 90 ml

The tablets covered with cover, 100 mg

The tablets covered with cover, 100 mg

Capsules of 100 mg

Capsules of 100 mg

Capsules of 200 mg

Capsules of 200 mg

1.6.2

A07B Intestinal adsorbents

Diosmektit (in children's practice)

Powder for preparation of suspension for internal application (for intake) 3 000 mg
suspension for internal application of 3,0 of / 15 ml

Powder for preparation of suspension for internal application (for intake) 3 000 mg
suspension for internal application of 3,0 of / 15 ml

The coal activated

Tablets of 250 mg

Tablets of 250 mg

1.6.3

A07C Electrolytes with carbohydrates

Salt complexes for oral regidratation

Powder for preparation of solution for internal application (for intake)

Powder for preparation of solution for internal application

1.6.4

The Means A07D reducing motor function of digestive tract

Loperamide

Capsules of 2 mg

Capsules of 2 mg

1.6.5

A07E the Resolvents operating on intestines

Mesalazin

The tablets covered with kishechnorastvorimy cover, 250 mg

The tablets covered with kishechnorastvorimy cover, 400 mg

The tablets covered with kishechnorastvorimy cover, 400 mg

The tablets covered with kishechnorastvorimy cover, 500 mg

Suppositories rectal 250 mg

Suppositories rectal 250 mg

Suppositories rectal 500 mg

Suppositories rectal 500 mg

Granules of the prolonged action of 1 g in sachet

Granules of the prolonged action of 2 g in sachet

Suspension of rectal 4 g / 60 ml in bottles of 60 ml

7,310

Sulfasalazin

The tablets covered with cover (the tablet covered with kishechnorastvorimy cover), 500 mg

The tablets covered with cover, 500 mg

1.6.6

A07F the Antidiarrheal means of biological origin regulating balance of intestinal microflora (probiotics)

Bakteriyny medicines for treatment of dysfunctions of intestines

The lyophilized powder for preparation of suspension for intake (the powder lyophilized for preparation of suspension for intake) of 5 doses

The lyophilized powder for preparation of suspension for intake (the powder lyophilized for preparation of suspension for intake) of 5 doses

1.7

The Means A09 normalizing digestion, including fermental means:

The Means A09A promoting digestion including enzymes

The multienzymes containing lipase, amylase, protease (for treatment of cystous fibrosis, when growing cancer of stomach into pancreas head)

Capsules are kishechnorastvorimy, 10 000 ED

0,187

Capsules kishechnorastvorimy 10 000 ED

Capsules are kishechnorastvorimy, 25 000 ED

0,37

1.8

Means A10 for treatment of diabetes:

1.8.1

A10A Insulin and their analogs

Insulin of the person (short action)

Solution for injections of 100 ME/ml in bottles of 10 ml

7,16

Solution for injections of 100 ME/ml in bottles of 10 ml

Solution for injections of 100 ME/ml in cartridges of 3 ml

Solution for injections of 100 ME/ml in cartridges of 3 ml

Insulin of the person (long action)

Suspension for injections of 100 ME/ml in bottles of 10 ml

7,16

Suspension for injections of 100 ME/ml in bottles of 10 ml

Suspension for hypodermic introduction (suspension for injections) 100 ME/ml in cartridges of 3 ml

Suspension for hypodermic introduction of 100 ME/ml in cartridges of 3 ml

Insulin aspart

Suspension for hypodermic introduction of 100 PIECES/ml in cartridges of 3 ml

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for hypodermic 100 PIECES/ml in cartridges of 3 ml

8,894

Insulin glargin (long action)

Solution for injections of 100 PIECES/ml in cartridges of 3 ml

13,453

Solution for injections of 100 PIECES/ml in cartridges of 3 ml

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for hypodermic introduction of 300 PIECES/ml in the syringe handles Solostar of 1,5 of ml

23,326

Insulin detemir (long action)

Solution for hypodermic introduction of 100 PIECES/ml in the syringe handles of 3 ml

12,526

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Insulin glulizin (short action)

Solution for hypodermic introduction of 100 PIECES/ml in the syringe handles Solostar of 3 ml

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for hypodermic introduction of 100 PIECES/ml in cartridges of 3 ml

10,292

Insulin of the person (aktrapid) (short action)

Solution for injections for hypodermic and intravenous administration of 100 ME/ml in bottles of 10 ml of NM

9,807

Solution for injections of 100 ME/ml in cartridges of 3 ml of NM Penfill

3,222

Solution for injections of 100 ME/ml in cartridges of 3 ml

Insulin of the person (protafan) (average duration of action)

Suspension for hypodermic introduction of 100 ME/ml in bottles of 10 ml of NM

9,278

Suspension for hypodermic introduction of 100 ME/ml in bottles of 10 ml

Suspension for hypodermic introduction of 100 ME/ml in cartridges of 3 ml of NM Penfill

3,222

Suspension for hypodermic introduction of 100 ME/ml in cartridges of 3 ml

Insulin of the person (gensulin)

Solution for injections of 100 ME/ml in bottles of 10 ml P

9,817

Suspension for injections of 100 ME/ml in bottles of 10 ml of N

9,817

Solution for injections of 100 ME/ml in cartridges of 3 ml P

3,725

Suspension for injections of 100 ME/ml in cartridges of 3 ml of N

3,725

Insulin of the person (insuman)

Solution for injections of 100 ME/ml in the syringe handles Solostar of 3 ml

Solution for injections of 100 ME/ml in bottles of 5 ml Slow motion of GT

Suspension for hypodermic introduction of 100 ME/ml in the syringe handles Solostar of 3 ml

Suspension for hypodermic introduction of 100 ME/ml in bottles of 5 ml Bazal GT

Insulin of the person (humulin)

Solution for injections of 100 ME/ml in bottles of 10 ml Regulyar

8,107

Suspension for hypodermic introduction of 100 ME/ml in bottles of 10 ml of NPH

8,107

Solution for injections of 100 ME/ml in cartridges of 3 ml Regulyar

5,923

Suspension for hypodermic introduction of 100 ME/ml in cartridges of 3 ml of NPH

5,904

1.8.2

A10B Oral gipoglikemiziruyushchy means

Glibenclamide

Mg tablets 3,5

Tablets of 5 mg

Tablets of 5 mg

Glikvidon

Tablets of 30 mg

0,117

Tablets of 30 mg

Gliclazide

Tablets of 30 mg with the modified release

Tablets of 30 mg with the modified release

Tablets of 60 mg with the modified release

Tablets of 60 mg with the modified release

Tablets of 80 mg

Tablets of 80 mg

Glimepirid

Tablets of 2 mg

Tablets of 4 mg

Tablets of 6 mg

Liraglutid

Solution for hypodermic introduction of 6 mg/ml 3 ml

Metformin

Tablets of 500 mg

Tablets of 500 mg

The tablets covered with cover, 500 mg

The tablets covered with cover, 500 mg

Tablets with the modified release of 500 mg

Tablets with the modified release of 500 mg

Tablets with the modified release of 750 mg

Tablets with the modified release of 750 mg

The tablets covered with cover, 850 mg

The tablets covered with cover, 850 mg

The tablets covered with cover, 1 000 mg

The tablets covered with cover, 1 000 mg

Tablets with the modified release of 1 000 mg

Tablets with the modified release of 1 000 mg

Metformin/glibenclamide

The tablets covered with cover, 500 mg / 2,5 of mg

The tablets covered with cover, 500 mg / 2,5 of mg

Tablets (the tablet covered with cover) of 500 mg / 5 mg

Tablets (the tablet covered with cover) of 500 mg / 5 mg

Vildagliptin

Tablets of 50 mg

0,768

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Dapagliflozin

The tablets covered with cover, 10 mg

Empagliflozin

The tablets covered with cover, 10 mg

The tablets covered with cover, 25 mg

1.9

A11 Vitamins

1.9.1

A11B Polyvitamins

b-karotin/Kislota ascorbic /
Retinolum palmitat/
D, L - a-tocopherol acetate
(in oncological practice)

Powder for preparation of solution for internal application in packets

Powder for preparation of solution for internal application in packets

1.9.2

A11C Vitamins A and D and their combinations

Kaltsitriol

Mkg 0,25 capsules

Retinolum (vitamin A)

Solution 34,4 of mg/ml of 10 ml, oil for internal application

Capsules of 33 000 ME

Capsules of 33 000 ME

Capsules of 5 000 ME

Capsules of 5 000 ME

Holekaltsiferol

Drops (solution) for intake of 15 000 ME/ml of 10 ml, 15 ml, 20 ml

Drops for intake of 15 000 ME/ml of 10 ml, 15 ml, 20 ml

Solution for intake oil (drop) 0,5 of mg/ml (20 000 ME/ml) of 10 ml

Solution for intake oil 0,5 of mg/ml

Capsules of 2 000 ME

Capsules of 2 000 ME

Capsules of 5 000 ME

Capsules of 5 000 ME

Capsules of 50 000 ME

Capsules of 50 000 ME

Ergokaltsiferol (vitamin D 2)

Solution 1,25 of mg/ml of 10 ml, oil for internal application

1.9.3

A11D B1 Vitamin and its combinations with B6 and B12 vitamins

Vitamin B6/B1/vitamin
B12 vitamin

Solution for intramuscular introduction of 2 ml

Solution for intramuscular introduction of 2 ml

Vitamin B6/B1/vitamin
Vitamin B12/lidocaine

Solution for intramuscular introduction of 2 ml

Solution for intramuscular introduction of 2 ml

Thiamine

Solution for intramuscular introduction of 50 mg/ml 1 ml

Solution for intramuscular introduction of 50 mg/ml 1 ml

1.9.4

A11G Ascorbic acid (vitamin C), including combinations with other means

Ascorbic acid

Solution for intravenous and intramuscular administration of 50 mg/ml 2 ml

Solution for intravenous and intramuscular administration of 50 mg/ml 2 ml

1.9.5

A11H Other vitamins (excepting combinations)

Pyridoxine

Solution for injections of 50 mg/ml 1 ml

Solution for injections of 50 mg/ml 1 ml

Powder (substance for powder preparation) (in children's practice)

Tocopherol

Drops for internal application oil (solution oil) 50 mg/ml 20 ml

Drops for internal application oil (solution oil) 100 mg/ml 20 ml

Drops for internal application oil (solution oil) 300 mg/ml 20 ml

1.10

A12 Mineral additives:

1.10.1

Means A12A on the basis of calcium

Calcium gluconate

Solution for injections of 100 mg/ml 5 ml, 10 ml

Tablets of 500 mg

Tablets of 500 mg

Calcium / Holekaltsiferol

Mg 66,7 ME/166,7 capsules

Mg 66,7 ME/166,7 capsules

Mg 133,4 ME/166,7 capsules

Mg 133,4 ME/166,7 capsules

Tablets chewing 500 mg / 0,005 of mg (200 ME)

Tablets chewing 500 mg / 0,005 of mg (200 ME)

1.10.2

A12C Other mineral additives

The complex medicines containing ions of potassium and magnesium

Tablets of 175 mg / 175 mg

The tablets covered with cover, 140 mg / 158 in mg

The tablets covered with cover, 140 mg / 158 in mg

Zinc sulfate

The tablets covered with cover, 124 mg

1.11

A14 Anabolic medicines for system application:

A14B Other anabolic substances

Methyluracil

Suppositories rectal 500 mg

1.12

A16 Other means for treatment of diseases of digestive tract and metabolic disorders:

1.12.1

A16AA of Amino acid and their derivatives

Ademetionin

The lyophilized powder for preparation of solution for injections of 500 mg

0,012

The tablets covered with kishechnorastvorimy cover, 500 mg

The tablets covered with kishechnorastvorimy cover, 500 mg

Gepavilag (valin/leytsin/
isoleucine / arginine / glycylglycine)

Granules for preparation of solution for intake

Granules for preparation of solution for intake

Tavamin (valin/izoleytsin/
leucine/taurine)

Capsules

Capsules

Left carnitine (for patients on hemodialysis)

Solution for intravenous administration (for injections) 200 mg/ml 5 ml

1,081

Solution for intravenous administration of 200 mg/ml 5 ml

1.12.2

A16AX Other means for treatment of diseases of digestive tract and metabolic disorders

Tioktovy acid

Solution for intravenous administration of 25 mg/ml 24 ml

1,45

Solution for intravenous administration of 25 mg/ml 24 ml

Concentrate for preparation of solution for infusions of 30 mg/ml 10 ml, 20 ml

1,45

Concentrate for preparation of solution for infusions of 30 mg/ml 10 ml, 20 ml

Solution for infusions of 30 mg/ml 10 ml, 20 ml

Solution for infusions of 12 mg/ml 50 ml

Solution for infusions of 12 mg/ml 50 ml

The tablets covered with cover, 300 mg

The tablets covered with cover, 600 mg

The tablets covered with cover, 600 mg

2

B Blood and haematogenic bodies

2.1

B01 Antitrombotichesky means:

2.1.1

B01AA Antagonists of vitamin K

Fenindion

Tablets of 30 mg

Varfarin

Mg tablets 2,5

Mg tablets 2,5

Tablets of 5 mg

2.1.2

B01AB Direct anticoagulants on the basis of heparin and its derivatives

Heparin

Solution for intravenous and hypodermic administration (for injections) 5 000 ME/ml of 5 ml

Solution for intravenous and hypodermic administration of 5 000 PIECES/ml 5 ml

Anti-thrombin III

The lyophilized powder for preparation of solution for intravenous infusions of 50 ME/ml 500 ME

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

The lyophilized powder for preparation of solution for intravenous infusions of 50 ME/ml of 1 000 ME

611,51

Dalteparin

Solution for injections of 2 500 ME of anti-Xa/0,2 of ml

2,773

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for injections of 5 000 ME of anti-Xa/0,2 of ml

4,121

Solution for injections of 10 000 ME of anti-Xa/1 of ml

6,413

Enoksaparin

Solution for injections 2 000 Anti-ha ml ME/0,2

2,373

Solution for injections 2 000 Anti-ha ml ME/0,2

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for injections 4 000 Anti-ha ml ME/0,4

2,668

Solution for injections 4 000 Anti-ha ml ME/0,4

Solution for injections 6 000 Anti-ha ml ME/0,6

3,599

Solution for injections 6 000 Anti-ha ml ME/0,6

Solution for injections 8 000 Anti-ha ml ME/0,8

4,544

Solution for injections 8 000 Anti-ha ml ME/0,8

Nadroparin

Solution for hypodermic introduction of 2 850 ME of anti-Xa/0,3 of ml

4,128

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for hypodermic introduction of 3 800 ME of anti-Xa/0,4 of ml

6,640

Solution for hypodermic introduction of 5 700 ME of anti-Xa/0,6 of ml

8,556

Solution for hypodermic introduction of 7 600 ME of anti-Xa/0,8 of ml

11,271

Solution for hypodermic introduction of 11 400 ME of anti-Xa/0,6 of ml

Bemiparin

Solution for injections of 2 500 ME of anti-Xa/0,2 of ml

2,328

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Solution for injections of 3 500 ME of anti-Xa/0,2 of ml

2,908

2.1.3

B01AC Inhibitors of aggregation of platelets, excepting heparin

Klopidogrel

The tablets covered with cover, 75 mg

The tablets covered with cover, 75 mg

Capsules of 75 mg

Capsules of 75 mg

Dipiridamol

For injections (for infusions) 5 mg/ml 2 ml

0,158

Tablets (the tablet covered with cover) of 25 mg

Acetilsalicylic acid

The tablets covered with kishechnorastvorimy cover, 50 mg

The tablets covered with kishechnorastvorimy cover (tablets kishechnorastvorimy, covered with cover) 75 mg

The tablets covered with kishechnorastvorimy cover (tablets kishechnorastvorimy, covered with cover) 75 mg

The tablets covered with cover, 75 mg

The tablets covered with cover, 75 mg

The tablets covered with kishechnorastvorimy cover, 100 mg

The tablets covered with kishechnorastvorimy cover (tablets kishechnorastvorimy, covered with cover) 150 mg

The tablets covered with kishechnorastvorimy cover (tablets kishechnorastvorimy, covered with cover) 150 mg

The tablets covered with cover, 150 mg

The tablets covered with cover, 150 mg

Ticagrelor

The tablets covered with cover, 60 mg

The tablets covered with cover, 60 mg

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

The tablets covered with cover, 90 mg

The tablets covered with cover, 90 mg

2.1.4

B01AD Fibrinolytic means on the basis of enzymes

Streptokinase

The powder lyophilized for preparation of solution for injections of 750 000 ME

The powder lyophilized for preparation of solution for injections of 750 000 ME

The powder lyophilized for preparation of solution for injections of 1 500 000 ME

The powder lyophilized for preparation of solution for injections of 1 500 000 ME

Alteplaza

Lyophilisate for preparation of solution for infusions of 50 mg

585,766

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Tenekteplaza

Lyophilisate (the powder lyophilized) for preparation of solution for intravenous administration of 10 000 PIECES 50 mg in bottles complete with the solvent

902,763

The powder lyophilized for preparation of solution for intravenous administration of 50 mg in bottles complete with the solvent

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

The powder lyophilized for preparation of solution for intravenous administration of 40 mg in bottles complete with the solvent

586,888

The powder lyophilized for preparation of solution for intravenous administration of 40 mg in bottles complete with the solvent

2.1.5

B01AE Direct inhibitors of thrombin

Dabigatrana eteksilat

Capsules of 75 mg

It is appointed based on the conclusion of medical consultation (except for crews of emergency medical service, intensive care units and intensive therapy)

Capsules of 110 mg

Capsules of 150 mg

Warning!!!

This is not a full text of document! Document shown in Demo mode!

If you have active License, please Login, or get License for Full Access.

With Full access you can get: full text of document, original text of document in Russian, attachments (if exist) and see History and Statistics of your work.

Get License for Full Access Now

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info

Effectively work with search system

Database include more 50000 documents. You can find needed documents using search system. For effective work you can mix any on documents parameters: country, documents type, date range, teams or tags.
More about search system

Get help

If you cannot find the required document, or you do not know where to begin, go to Help section.

In this section, we’ve tried to describe in detail the features and capabilities of the system, as well as the most effective techniques for working with the database.

You also may open the section Frequently asked questions. This section provides answers to questions set by users.

Search engine created by SoyuzPravoInform LLC.